These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27565089)

  • 21. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump.
    Figueredo FG; Ramos ITL; Paz JA; Silva TMS; Câmara CA; de Morais Oliveira-Tintino CD; Tintino SR; de Farias PAM; Menezes IRA; Coutinho HDM; Fonteles MMF
    Infect Genet Evol; 2020 Oct; 84():104370. PubMed ID: 32445918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
    Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the resistance to norfloxacin in
    de Sousa JN; de Oliveira ABM; Ferreira AK; Silva E; de Sousa LMS; França Rocha MC; de JP; Júnior S; William Kaatz G; da Silva Almeida JRG; de Souza JSN; Medeiros Barreto H
    Nat Prod Res; 2021 Feb; 35(4):681-685. PubMed ID: 30938178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of antibacterial activity and reversal of the NorA and MepA efflux pump of estragole against Staphylococcus aureus bacteria.
    da Costa RHS; Rocha JE; de Freitas TS; Pereira RLS; Junior FNP; de Oliveira MRC; Batista FLA; Coutinho HDM; de Menezes IRA
    Arch Microbiol; 2021 Aug; 203(6):3551-3555. PubMed ID: 33942156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro and In Silico Inhibition of Staphylococcus aureus Efflux Pump NorA by α-Pinene and Limonene.
    de Araújo ACJ; Freitas PR; Dos Santos Barbosa CR; Muniz DF; de Almeida RS; Alencar de Menezes IR; Ribeiro-Filho J; Tintino SR; Coutinho HDM
    Curr Microbiol; 2021 Sep; 78(9):3388-3393. PubMed ID: 34268598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.
    Dos Santos Barbosa CR; Scherf JR; de Freitas TS; de Menezes IRA; Pereira RLS; Dos Santos JFS; de Jesus SSP; Lopes TP; de Sousa Silveira Z; de Morais Oliveira-Tintino CD; Júnior JPS; Coutinho HDM; Tintino SR; da Cunha FAB
    J Bioenerg Biomembr; 2021 Aug; 53(4):489-498. PubMed ID: 34159523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
    Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ
    Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the Drug Resistance by
    E Silva AKF; Dos Reis AC; Pinheiro EEA; de Sousa JN; de Alcântara Oliveira FA; Moura AKS; de Sousa L Neto J; das Graças L Citó AM; Siqueira-Júnior JP; Kaatz GW; Barreto HM
    Curr Drug Metab; 2021; 22(2):114-122. PubMed ID: 32445452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
    Wani NA; Singh S; Farooq S; Shankar S; Koul S; Khan IA; Rai R
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4174-8. PubMed ID: 27503686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid.
    Dos Santos JFS; Tintino SR; de Freitas TS; Campina FF; de A Menezes IR; Siqueira-Júnior JP; Coutinho HDM; Cunha FAB
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():22-28. PubMed ID: 30017074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.